Skip to main content
Caplight Logo









Emerald

Emerald

Private
LondonHealthcare & Life Scienceshttps://withemerald.com

Last Round

Grant

Oct 20, 2026

Total Funding Raised

$4.71M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Emerald operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in October 2026.

Emerald is a healthtech company that provides a preventive health platform integrating diagnostic blood testing, AI-driven analysis, and virtual GP consultations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Healthcare Analytics, Sports & Fitness, Precision Medicine

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Emerald Comparables

Compare Emerald with similar companies based on industry and business-model similarity.

Emerald comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kyma Health
86%
Do Health
84%
Axo Longevity
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Emerald Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 20, 2026
Pre SeedJan 29, 2026
AngelMay 14, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Anton Shchipanov

Co-Founder, CTO

Founding Team

Dan McNally

Co-Founder, Chief Medical Officer

Founding Team

Alexander Badalyan

Co-Founder, CEO

Founding Team

For institutional investors. Book with your work email.

Emerald Investors

Notable investors and investment history

Emerald investors
InvestorRounds
Granatus VenturesPre Seed
Scientia VenturesGrant, Angel
Innovate UKGrant
Boost Capital PartnersPre Seed
Highgoal Capital ManagementGrant
Sequel Venture PartnersGrant
Leafy TunnelGrant, Angel
Book a demo to see all 8 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 20, 2026

    $1.85M raised from multiple venture capital firms.

  • Aug 22, 2026

    Monthly visitors increased 43% MoM, reaching 26.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingOct 20, 2026

    Emerald Labs Ltd receives $934K in financing, reported as a £700,000 Innovate UK grant, while venture capital investors provide the remaining funding in October 2026; Boost Capital Partners, Sequel, and Highgoal Capital participate alongside existing investors.

  • receives_financingOct 20, 2026

    Emerald Labs Ltd raises $1.87M in new funding, reported as £1.4 million, with £700,000 from Innovate UK and £700,000 from venture capital investors, bringing total funding to £2.9 million on Oct 20th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Emerald Filings

Explore SEC and related filing metadata, where available.

Emerald filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Emerald's valuation, stock price, and market status.

Is Emerald a public or private company?

Emerald is a private company.

What is the current stock price of Emerald?

Emerald is a private company, so its shares have no public market price. Caplight tracks Emerald's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Emerald worth (valuation)?

Valuation information for Emerald is not publicly available.

Can I buy Emerald stock?

Emerald shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Emerald's last funding round?

Emerald's most recent funding round was Grant on October 20, 2026.

Who are the main investors in Emerald?

Key investors in Emerald include Boost Capital Partners, Boost Capital Partners.

Will Emerald IPO soon?

No public IPO plans have been announced for Emerald.

How can I track Emerald secondary market activity?

Caplight tracks bids, offers, and trades in Emerald's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range13
Year Founded2024
Last FundingOct 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?